V Imbesi
Overview
Explore the profile of V Imbesi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
409
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marmo R, Rotondano G, Casetti T, Manes G, Chilovi F, Sprujevnik T, et al.
Endoscopy
. 2009 Jul;
41(7):587-92.
PMID: 19588285
Background And Study Aims: Capsule endoscopy is considered the diagnostic procedure of choice in patients with obscure gastrointestinal bleeding (OGIB). Double-balloon endoscopy (DBE) offers both diagnostic and therapeutic potential, but...
2.
Manes G, Imbesi V, Ardizzone S, Cassinotti A, Bosani M, Massari A, et al.
Dig Liver Dis
. 2008 Nov;
41(9):653-8.
PMID: 19036651
Introduction: Colonoscopy is a necessary tool in the management of Crohn's disease, but the benefit achieved by the procedure is a matter of debate. In the present study we evaluate...
3.
Manes G, Imbesi V, Bianchi-Porro G
Endoscopy
. 2007 Apr;
39 Suppl 1:E98.
PMID: 17440863
No abstract available.
4.
Ardizzone S, Maconi G, Russo A, Imbesi V, Colombo E, Bianchi Porro G
Gut
. 2005 Jun;
55(1):47-53.
PMID: 15972298
Background And Aims: There are limited evidence based data concerning the use of azathioprine in ulcerative colitis. We aimed to compare the efficacy of azathioprine and oral 5-aminosalicylic acid in...
5.
Ardizzone S, Bollani S, Manzionna G, Colombo E, Maconi G, Imbesi V, et al.
Ann Ital Chir
. 2004 Jun;
74(6):621-5.
PMID: 15206802
Crohns Disease (CD) is a chronic intestinal inflammatory disease of unknown origins that cannot be definitely resolved with surgical intervention. Therefore, pharmacologic therapies are of great importance both in preventing...
6.
Ardizzone S, Bollani S, Manzionna G, Imbesi V, Colombo E, Bianchi Porro G
Dig Liver Dis
. 2003 Oct;
35(9):619-27.
PMID: 14563183
Background And Aims: The efficacy of azathioprine in the treatment of chronic active Crohn's disease is well established. However, this drug has a long onset of action. Methotrexate has also...
7.
Parente F, Sainaghi M, Sangaletti O, Imbesi V, Maconi G, Anderloni A, et al.
Aliment Pharmacol Ther
. 2002 Mar;
16(3):553-7.
PMID: 11876710
Background: Proton pump inhibitors may interfere with the accuracy of the (13)C-urea breath test, but little information is available on the effect of standard doses of various proton pump inhibitors...
8.
Maconi G, Russo A, Imbesi V, Cucino C, Bianchi Porro G
Dig Liver Dis
. 2001 Aug;
32(4):275-80.
PMID: 11515622
Aims: To compare the efficacy of one-week versus two-week treatment with lansoprazole, amoxycillin and clarithromycin in inducing healing of Helicobacter pylori-positive duodenal ulcers as well as to investigate the role...
9.
Parente F, Negrini R, Imbesi V, Maconi G, Sainaghi M, Vago L, et al.
Scand J Gastroenterol
. 2001 May;
36(5):474-8.
PMID: 11346199
Background: Although the association between Helicobacter pylori infection and gastric autoimmunity is now well established, to date little is known about the significance of anticanalicular autoantibodies in patients with duodenal...
10.
Maconi G, Parente F, Russo A, Vago L, Imbesi V, Bianchi Porro G
Am J Gastroenterol
. 2001 Mar;
96(2):359-66.
PMID: 11232676
Objectives: Seven-day proton pump inhibitor (PPI)-based triple therapies are the first-line anti-Helicobacter pylori regimens; to date, however, there is still no agreement concerning all the predictors of H. pylori cure...